Literature DB >> 22551841

An automated decision-support system for non-proliferative diabetic retinopathy disease based on MAs and HAs detection.

Marwan D Saleh1, C Eswaran.   

Abstract

Diabetic retinopathy (DR) has become a serious threat in our society, which causes 45% of the legal blindness in diabetes patients. Early detection as well as the periodic screening of DR helps in reducing the progress of this disease and in preventing the subsequent loss of visual capability. This paper provides an automated diagnosis system for DR integrated with a user-friendly interface. The grading of the severity level of DR is based on detecting and analyzing the early clinical signs associated with the disease, such as microaneurysms (MAs) and hemorrhages (HAs). The system extracts some retinal features, such as optic disc, fovea, and retinal tissue for easier segmentation of dark spot lesions in the fundus images. That is followed by the classification of the correctly segmented spots into MAs and HAs. Based on the number and location of MAs and HAs, the system quantifies the severity level of DR. A database of 98 color images is used in order to evaluate the performance of the developed system. From the experimental results, it is found that the proposed system achieves 84.31% and 87.53% values in terms of sensitivity for the detection of MAs and HAs respectively. In terms of specificity, the system achieves 93.63% and 95.08% values for the detection of MAs and HAs respectively. Also, the proposed system achieves 68.98% and 74.91% values in terms of kappa coefficient for the detection of MAs and HAs respectively. Moreover, the system yields sensitivity and specificity values of 89.47% and 95.65% for the classification of DR versus normal.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22551841     DOI: 10.1016/j.cmpb.2012.03.004

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  8 in total

1.  An exudate detection method for diagnosis risk of diabetic macular edema in retinal images using feature-based and supervised classification.

Authors:  D Marin; M E Gegundez-Arias; B Ponte; F Alvarez; J Garrido; C Ortega; M J Vasallo; J M Bravo
Journal:  Med Biol Eng Comput       Date:  2018-01-10       Impact factor: 2.602

2.  Computer-aided diabetic retinopathy detection using trace transforms on digital fundus images.

Authors:  Karthikeyan Ganesan; Roshan Joy Martis; U Rajendra Acharya; Chua Kuang Chua; Lim Choo Min; E Y K Ng; Augustinus Laude
Journal:  Med Biol Eng Comput       Date:  2014-06-24       Impact factor: 2.602

3.  High-frequency-based features for low and high retina haemorrhage classification.

Authors:  Salim Lahmiri
Journal:  Healthc Technol Lett       Date:  2017-02-16

4.  Distinguising Proof of Diabetic Retinopathy Detection by Hybrid Approaches in Two Dimensional Retinal Fundus Images.

Authors:  Karkuzhali S; Manimegalai D
Journal:  J Med Syst       Date:  2019-05-08       Impact factor: 4.460

5.  A transfer learning based deep learning model to diagnose covid-19 CT scan images.

Authors:  Sanat Kumar Pandey; Ashish Kumar Bhandari; Himanshu Singh
Journal:  Health Technol (Berl)       Date:  2022-06-09

Review 6.  A Review on Recent Developments for Detection of Diabetic Retinopathy.

Authors:  Javeria Amin; Muhammad Sharif; Mussarat Yasmin
Journal:  Scientifica (Cairo)       Date:  2016-09-29

7.  A Clinical Decision Support System for Diabetic Retinopathy Screening: Creating a Clinical Support Application.

Authors:  Pedro Romero-Aroca; Aida Valls; Antonio Moreno; Ramon Sagarra-Alamo; Josep Basora-Gallisa; Emran Saleh; Marc Baget-Bernaldiz; Domenec Puig
Journal:  Telemed J E Health       Date:  2018-02-21       Impact factor: 3.536

8.  Automatic non-proliferative diabetic retinopathy screening system based on color fundus image.

Authors:  Zhitao Xiao; Xinpeng Zhang; Lei Geng; Fang Zhang; Jun Wu; Jun Tong; Philip O Ogunbona; Chunyan Shan
Journal:  Biomed Eng Online       Date:  2017-10-26       Impact factor: 2.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.